We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Surgical Innovations Group Plc | LSE:SUN | London | Ordinary Share | GB0004016704 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.50 | 0.40 | 0.60 | 0.50 | 0.50 | 0.50 | 1,162,877 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Surgical,med Instr,apparatus | 11.34M | 264k | 0.0003 | 16.67 | 4.66M |
From Apr 2019 to Apr 2024
TIDMSUN
RNS Number : 5937T
Surgical Innovations Group PLC
09 January 2017
Surgical Innovations Group plc
("SI Group" or the "Company")
Year-end trading update
Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, provides an update on trading for the year ended 31 December 2016.
The trading performance for the year was slightly ahead of the board's previous expectations. Revenues increased by approximately 10% compared with the prior year, and exceeded GBP6m. Gross margins showed continued improvement and came into line with a target range of above 32% of revenues for the full year. The net result for the year is expected to show a return to profitability at the profit before taxation level.
Bank borrowings were fully repaid prior to the end of the financial year, and year end net cash balances were approximately GBP0.8m (2015: net bank debt of GBP1.0m).
The integration of the laparoscopic business and assets of Surgical Dynamics Limited, acquired in November 2016, is continuing and progress is satisfactory. This work is expected to continue through the first quarter of 2017, with manufacture of these additional products underway at Leeds by the end of March.
Audited results for the year ended 31 December 2016 will be released in mid-March 2017.
The announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.
For further information please contact:
Surgical Innovations Group www.sigroupplc.com plc Nigel Rogers, Executive Tel: 0113 230 7597 Chairman Melanie Ross, COO & Finance Director WH Ireland Limited (NOMAD Tel: 0113 394 6600 & Broker) Tim Feather/Ed Kennedy Walbrook PR (Financial Tel: 020 7933 8780 or si@walbrookpr.com PR & Investor Relations) Paul McManus Mob: 07980 541 893
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTSSAFWMFWSEEF
(END) Dow Jones Newswires
January 09, 2017 02:00 ET (07:00 GMT)
1 Year Surgical Innovations Chart |
1 Month Surgical Innovations Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
